HPV vaccine acceptability in HIV-infected and HIV negative men who have sex with men (MSM) in Ireland

References

• Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol 2004 32:16-24, Suppl 1:S16–24
   Web of Science ®Google Scholar
• Hartwig S, Syrjänen S, Dominiak-Felden G, Brotons M, Castellsagué X. Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review. BMC Cancer 2012; 12:30; PMID:22260541; http://dx.doi.org/10.1186/1471-2407-12-30
   PubMed Web of Science ®Google Scholar
• Sadlier C, Rowley D, Morley D, Surah S, O'Dea S, Delamere S, O'Leary J, Smyth P, Clarke S, Sheils O, et al. Prevalence of human papillomavirus in men who have sex with men in the era of an effective vaccine; a call to act. HIV Med 2014 Sep; 15(8):499-504; PMID:24655896; http://dx.doi.org/10.1111/hiv.12150
   PubMed Web of Science ®Google Scholar
• Van Aar F, Mooij S, Van der Sande M, Speksnijder AG, Stolte IG, Meijer CJ, Verhagen DW, King AJ, de Vries HJ, Schim van der Loeff MF. Anal and penile high-risk human papillomavirus prevalence in HIV-negative and HIV-infected MSM. AIDS 2013 November 28; 27(18):2921-31
   PubMed Web of Science ®Google Scholar
• Goldstone S, Palefsky J, Giuliano A, Moreira ED Jr, Aranda C, Jessen H, Hillman RJ, Ferris DG, Coutlee F, Liaw KL, et al. Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative Men who have sex with Men. J Infect Dis 2011; 203(1):66-74; PMID:21148498; http://dx.doi.org/10.1093/infdis/jiq016
   PubMed Web of Science ®Google Scholar
• Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003; 53:5-26.
   PubMed Web of Science ®Google Scholar
• Patel P, Hanson DL, Sullivan PS, Novak RM, Moorman AC, Tong TC, Holmberg SD, Brooks JT, Adult and Adolescent Spectrum of Disease Project and HIV Outpatient Study Investigators. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003. Ann Intern Med 2008; 148:728-36; PMID:18490686; http://dx.doi.org/10.7326/0003-4819-148-10-200805200-00005
   PubMed Web of Science ®Google Scholar
• Giuliano AR, Palefsky JM, Goldstone S, Moreira ED Jr, Penny ME, Aranda C, Vardas E, Moi H, et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med 2011; 364.5:401-11; PMID:21288094; http://dx.doi.org/10.1056/NEJMoa0909537
   PubMed Web of Science ®Google Scholar
• FUTUREII StudyGroup. Quadrivalent vaccine against human papillomavirus to prevent highgrade cervical lesions. N Engl J Med 2007; 356:1915-27; PMID:17494925; http://dx.doi.org/10.1056/NEJMoa061741
   PubMed Web of Science ®Google Scholar
• Morbidity and Mortality Weekly Report (MMWR). March 27, 2015; 64(11):300-4. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6411a3.htm
   Google Scholar
• Kim JJ, Sue J. Goldie. Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States. BMJ 2009; 339: b3884; PMID:19815582; http://dx.doi.org/10.1136/bmj.b3884
   PubMed Web of Science ®Google Scholar
• Ali H, Donovan B, Wand H, Read TR, Regan DG, Grulich AE, Fairley CK, Guy RJ. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ 2013; 346:f2032; PMID:23599298
   PubMed Web of Science ®Google Scholar
• Kim JJ. Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost effectiveness modelling analysis. Lancet Infect Dis 2010 December; 10(12):845-52; PMID:21051295; http://dx.doi.org/10.1016/S1473-3099(10)70219-X
   PubMed Web of Science ®Google Scholar
• Deshmukh AA, Chiao EY, Das P, Cantor SB. Clinical effectiveness and cost-effectiveness of quadrivalent human papillomavirus vaccination in HIV-negative men who have sex with men to prevent recurrent high-grade anal intraepithelial neoplasia. Vaccine 2014; 32:6941-7; PMID:25444820; http://dx.doi.org/10.1016/j.vaccine.2014.10.052
   PubMed Web of Science ®Google Scholar
• Deshmukh A, Chiao E, Nyitray A, Das P, Cantor S. Long-term outcomes of adding HPV vaccine to the anal intraepithelial neoplasia treatment regimen in HIV-positive men who have sex with Men. Clin Infect Dis 2015; 61(10):1527-35; PMID:26223993
   PubMed Web of Science ®Google Scholar
• Swedish KA, Factor SH, Goldstone SE. Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study. Clin Infect Dis 2012 Apr; 54(7):891-8; PMID:22291111; http://dx.doi.org/10.1093/cid/cir1036
   PubMed Web of Science ®Google Scholar
• Swedish KA, Goldstone SE. Prevention of anal condyloma with quadrivalent human papillomavirus vaccination of older men who have sex with men. PLoS One 2014; 9:e93393; PMID:24714693; http://dx.doi.org/10.1371/journal.pone.0093393
   PubMed Web of Science ®Google Scholar
• Joint committee on Immunisation and Vaccination (JCVI), Department of Health and Public Health England. Interim statement on HPV vaccination of men who have sex with men. November 2014. 1-9. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/373531/JCVI_interim_statement_HPV_vacc.pdf
   Google Scholar
• Nadarzynski T, Smith S, Richardson D. Human papillomavirus and vaccine-related perceptions among men who have sex with men: a systematic review. Sex Transm Infect 2014; 90:515-23; PMID:24787367; http://dx.doi.org/10.1136/sextrans-2013-051357
   PubMed Web of Science ®Google Scholar
• Newman PA, Logie CH, Doukas N, Asakura K. HPV vaccine acceptability among men: a systematic review and meta-analysis. Sex Transm Infect 2013 Nov; 89(7):568-74; PMID:23828943; http://dx.doi.org/10.1136/sextrans-2012-050980
   PubMed Web of Science ®Google Scholar
• Rank C, Gilbert M, Ogilvie G, Jayaraman GC, ManCount Study Team. Acceptability of human papillomavirus vaccination and sexual experience prior to disclosure to health care providers among men who have sex with men in Vancouver, Canada: implications for targeted vaccination programs. Vaccine 2012 Aug 24; 30(39):5755-60; PMID:22796376; http://dx.doi.org/10.1016/j.vaccine.2012.07.001
   PubMed Web of Science ®Google Scholar
• Reiter PL, Brewer NT, McRee A-L, Gilbert P, Smith JS. Acceptability of HPV vaccine among a national sample of Gay and Bisexual Men. Sex Trans Dis 2010; 37(3):197-203; PMID:20118831; http://dx.doi.org/10.1097/OLQ.0b013e3181bf542c
   PubMed Web of Science ®Google Scholar
• Simatherai D, Bradshaw C, Fairley C. What men who have sex with men think about the human papillomavirus vaccine. Sex Transm Infect 2009; 85:148-1; PMID:19153110; http://dx.doi.org/10.1136/sti.2008.032581
   PubMed Web of Science ®Google Scholar
• Lau JTF, Wang Z, Kim JH, Lau M, Lai CHY, Mo PKH. Acceptability of HPV vaccines and associations with perceptions related to HPV and HPV vaccines among Men who have sex with Men in Hong Kong. PLoS One 2013; 8(2):e57204; PMID:23451188; http://dx.doi.org/10.1371/journal.pone.0057204
   PubMedGoogle Scholar
• Pitts MK, Fox C, Willis J, Anderson J. What do gay men know about human papillomavirus? Australian gay men's knowledge and experience of anal cancer screening and human papillomavirus. Sex Transm Dis 2007; 34:170-3; PMID:16837830; http://dx.doi.org/10.1097/01.olq.0000230436.83029.ce
   PubMed Web of Science ®Google Scholar
• Vikrant S, Castle P, Follansbee S, Borgonovo S, Tokugawa D, Schwartz LM, Lorey TS, LaMere BJ, Gage JC, Fetterman B, et al. Human papillomavirus genotype attribution and estimation of preventable fraction of anal intraepithelial neoplasia cases among HIV-infected men who have sex with men. J Infect Dis 2013; 207:392-401; PMID:23162133; http://dx.doi.org/10.1093/infdis/jis694
   PubMed Web of Science ®Google Scholar
• Poynten IM, Tabrizi S, Jin F, Hurley A, Hillman R, Templeton D, Machalek D, Cornall A, Roberts J, Garland S, Fairley C, Grulich A, on behalf of the SPANC Study Team. Potential impact of human papillomavirus (HPV) vaccination among HIV positive and HIV-negative homosexual men: vaccine-preventable anal HPV types in the SPANC study. 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention, June 30-July 3, 2013, Poster exhibition WEPE536, Kuala Lumpur. http://pag.ias2013.org/abstracts.aspx?aid=822
   Google Scholar
• Palefsky JM, Giuliano AR, Goldstone S, Moreira ED Jr, Aranda C, Jessen H, Hillman R, Ferris D, Coutlee F, Stoler MH, et al.: HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011, 365(17):1576-85
   PubMed Web of Science ®Google Scholar
• Rock C, DeBarra E, Sadlier C, Kelly S, Dowling C, McNally C, Bergin C. Impact of a new vaccine clinic on hepatitis B vaccine completion and immunological response rates in an HIV-positive cohort. J Infect Public Health 2013:6:3 173-8; PMID:23668461; http://dx.doi.org/10.1016/j.jiph.2012.11.001
   PubMed Web of Science ®Google Scholar
• Hoots BE, Palefsky JM, Pimenta JM, Smith JS. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 2009 May 15; 124(10):2375-83; PMID:19189402; http://dx.doi.org/10.1002/ijc.24215
   PubMed Web of Science ®Google Scholar
• Kreuter A, Potthoff A, Brockmeyer NH, Gambichler T, Swoboda J, Stücker M, Schmitt M, Pfister H, Wieland U, German Competence Network HIV/AIDS. Anal carcinoma in human immunodeficiency virus-positive men: results of a prospective study from Germany. Br J Dermatol 2010; 162:1269-77; PMID:20184584; http://dx.doi.org/10.1111/j.1365-2133.2010.09712.x
   PubMed Web of Science ®Google Scholar